CURE® Summer 2022

The stories in this issue of CURE illustrate how patients with cancer have become partners in therapeutic advances.

Care teams often implant a chemo port into patients with cancer to provide easy access for blood draws and to deliver treatments such as chemotherapy and antibiotics. Here, as part of its Heal at Home series, CURE® works with a nurse to provide a guide for patients to care for their port.

In CURE®’s “Speaking Out” video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for brain metastases in breast cancer and how patients can take part in driving their care.

The FDA approval of the first poly (adenosine diphosphate-ribose) polymerase, or PARP, inhibitor in the 2010s has drastically changed how patients with gynecologic cancers are treated.

Cancer treatment has evolved over the past 20 years, but has the way it is depicted in television and movies also changed?

Many patients with cancer who have limited financial resources or high insurance co-pays have started to use crowdfunding campaigns to pay for the daunting bills associated with their treatment and subsequent care.

The use of newer tools and techniques may be reducing the risk of surgical site infections and other complications in patients receiving treatment for gynecologic cancers.

It is incredibly important that patients with MPNs inform their health care team of any symptoms they are experiencing, according to an expert from The Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center.

One patient turned her diagnosis of multiple myeloma into a way to educate others as an advocate.

Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, according to experts, may be transformative for patients.